| Contents |
"Natural history" clinical trials : an enduring contribution to modern medical practice / Edward M. Scolnick, Eve E. Slater, George W. Williams -- Angiotensin-converting enzyme inhibitors / Joel Menard, Arthur Patchett -- HMG-CoA reductase inhibitors / Roger Illingworth, Jonathan A. Tolbert -- Cyclooxygenase-2 inhibitors / Alan S. Nies -- 5[alpha]-reductase inhibitors / John D. McConnell, Elizabeth Stoner -- Peroxisome proliferator-activated receptor (PPAR)[gamma] agonists for diabetes / David E. Moller, Douglas A. Greene -- Discovery and clinical development of HIV-1 protease inhibitors / Joel Huff, James Kahn -- Calcineurin inhibitors and the generalization of the presenting protein strategy / Kurt W. Vogel ... [et al.] -- Pure selective estrogen receptor modulators, new molecules having absolute cell specificity ranging from pure antiestrogenic to complete estrogen-like activities / Fernand Labire ... [et al.] -- Monoclonal antibody therapy / John W. Park, Josef Smolen -- Glucan synthase inhibitors as intifungal agents / Myra B. Kurtz, John H. Rex. |
